Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 224

Similar articles for PubMed (Select 18430571)

1.

Myopathy associated with chronic orlistat consumption: a case report.

Ringman JM, Mozaffar T.

Neuromuscul Disord. 2008 May;18(5):410-2. doi: 10.1016/j.nmd.2008.03.005. Epub 2008 Apr 21.

PMID:
18430571
2.

[Pharmacological therapy of obesity].

Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian.

PMID:
18773755
3.

How do you treat patients with myalgia who take statins?

Siddiqi SA, Thompson PD.

Curr Atheroscler Rep. 2009 Jan;11(1):9-14. Review.

PMID:
19080722
4.

Strategies for the prevention and treatment of statin-induced myopathy: is there a role for ubiquinone supplementation?

Koumis T, Nathan JP, Rosenberg JM, Cicero LA.

Am J Health Syst Pharm. 2004 Mar 1;61(5):515-9. Review. No abstract available.

PMID:
15018231
5.

Statin-associated myopathy with normal creatine kinase levels.

Teichholz LE.

Ann Intern Med. 2003 Jun 17;138(12):1008; author reply 1008-9. No abstract available.

PMID:
12809468
6.

Statin-associated myopathy with normal creatine kinase levels. Case report from a Norwegian family.

Trøseid M, Henriksen OA, Lindal S.

APMIS. 2005 Sep;113(9):635-7.

PMID:
16218940
7.

Additive gastrointestinal effects with concomitant use of olestra and orlistat.

Heck AM, Calis KA, McDuffie JR, Carobene SE, Yanovski JA.

Ann Pharmacother. 2002 Jun;36(6):1003-5.

PMID:
12022901
8.

The safety profiles of orlistat and sibutramine: results of prescription-event monitoring studies in England.

Perrio MJ, Wilton LV, Shakir SA.

Obesity (Silver Spring). 2007 Nov;15(11):2712-22.

PMID:
18070762
10.

Orlistat use and the body mass index.

Goldstein MR.

Am J Cardiol. 2000 Nov 1;86(9):1055-6. No abstract available.

PMID:
11127952
11.

Constipation, polyuria, polydipsia, and edema associated with orlistat.

Packard KA, Wurdeman RL, Reyes AP.

Ann Pharmacother. 2002 Jul-Aug;36(7-8):1168-70.

PMID:
12086548
12.

[Orlistat: medically induced malabsorption of the fat in the treatment of severe obesity].

Hendel HW, Andersen T.

Ugeskr Laeger. 1999 Nov 1;161(44):6068-72. Review. Danish. No abstract available.

PMID:
10778347
13.

The long-term influence of orlistat on dietary intake in obese subjects with components of metabolic syndrome.

Svendsen M, Helgeland M, Tonstad S.

J Hum Nutr Diet. 2009 Feb;22(1):55-63. doi: 10.1111/j.1365-277X.2008.00920.x.

PMID:
19192027
14.

[Pharmacological sheet. Orlistat, oral administration (Xenical, Alli). ].

[No authors listed]

J Pharm Belg. 2009 Jun;(2):67-8. Review. French. No abstract available.

PMID:
19739531
15.

Lipid-lowering agents and myopathy.

Wortmann RL.

Curr Opin Rheumatol. 2002 Nov;14(6):643-7. Review.

PMID:
12410084
16.

Coenzyme Q10 depletion: etiopathogenic or predisposing factor in statin associated myopathy?

Chatzizisis YS, Vaklavas C, Giannoglou GD.

Am J Cardiol. 2008 Apr 1;101(7):1071. doi: 10.1016/j.amjcard.2007.12.005. No abstract available.

PMID:
18359340
17.

Clofibrate-induced myopathy in a patient with primary hypothyroidism.

Hattori N, Shimatsu A, Murabe H, Nishimura M, Nakamura H, Imura H.

Jpn J Med. 1990 Sep-Oct;29(5):545-7.

18.

Myopathy associated with statin therapy.

Hilton-Jones D.

Neuromuscul Disord. 2008 Jan;18(1):97-8. Epub 2007 Sep 24. No abstract available.

PMID:
17892936
19.

[A case of acute cholestatic hepatitis associated with Orlistat].

Kim DH, Lee EH, Hwang JC, Jeung JH, Kim do H, Cheong JY, Cho SW, Kim YB.

Taehan Kan Hakhoe Chi. 2002 Sep;8(3):317-20. Korean.

20.

Pharmacodynamic equivalence of two orlistat capsule formulations in healthy volunteers under fed conditions.

Di Marco M, Marier JF, Ducharme MP, Morin I, Engel C, Gulbranson S, Thudi NR, Murpani D, Rampal A, Monif T, Koundinya TS, Deo K, Monif T.

Int J Clin Pharmacol Ther. 2008 Jun;46(6):319-26.

PMID:
18541129
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk